The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery

Treatments for refractory glaucoma include trabeculectomy, in which a filtering bleb is created to reduce aqueous pressure. Mitomycin C (MMC) is often used as an adjuvant to reduce post-trabeculectomy bleb scarring and consequent failure. However, scarring sometimes still occurs. Thus, we searched f...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Yamamoto, Kotaro, Kokubun, Taiki, Sato, Kota, Akaishi, Takahiro, Shimazaki, Atsushi, Nakamura, Masatsugu, Shiga, Yukihiro, Tsuda, Satoru, Omodaka, Kazuko, Saya, Hideyuki, Nakazawa, Toru
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917768/
https://ncbi.nlm.nih.gov/pubmed/31848363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-55365-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller